(19)
(11) EP 2 204 185 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 A1)

(48) Corrigendum issued on:
27.10.2010 Bulletin 2010/43

(43) Date of publication:
07.07.2010 Bulletin 2010/27

(21) Application number: 10075114.8

(22) Date of filing: 02.11.1995
(51) International Patent Classification (IPC): 
A61K 39/02(2006.01)
A61K 39/102(2006.01)
A61K 39/095(2006.01)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 02.11.1994 GB 9422096

(62) Application number of the earlier application in accordance with Art. 76 EPC:
03075069.9 / 1312377
95935550.4 / 0789587

(71) Applicant: Novartis Vaccines and Diagnostics S.r.l.
53100 Siena (SI) (IT)

(72) Inventors:
  • Ceccarini, Costante
    53100 Siena (IT)
  • D'Ascenzi, Sandro
    53100 Siena (IT)
  • Costantino, Paolo
    53100 Siena (IT)
  • Norelli, Francesco
    53100 Siena (IT)
  • Gianozzi, Aldo
    53100 Siena (IT)

(74) Representative: Marshall, Cameron John et al
Carpmaels & Ransford One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

 
Remarks:
This application was filed on 16-03-2010 as a divisional application to the application mentioned under INID code 62.
 


(54) Combined meningitis vaccine


(57) A combined vaccine for bacterial meningitis comprises Hib and MenC saccharides.